Quartesian and Medrio have had a solid partnership since 2010 and have partnered together in over 150 studies. In this podcast, we’ll discuss the foundation of our successful partnership, eSource, and the innovative ways we are collaborating with Quarteisan on a COVID-19 study currently underway.
Phastar and Medrio have been partnering together on trials for the past 3 years, culminating in a unique way to visualize clinical trial data....
Australia and New Zealand have not been impacted as much as North America and the EU with regards to COVID-19. For this reason, and...
Approximately 39.5% of all men and women will be diagnosed with cancer at some point during their lifetimes, and yet only 8% of oncology...